All about TRUS

In this article here below, distinguished consultant urologist, Mr Christopher Ogden, shares expert insights into what TRUS is, and how it can help treat and detect prostate cancer. 

What is TRUS?

A transrectal ultrasound (TRUS) is a crucial diagnostic tool in urology, particularly for assessing prostate-related conditions. TRUS works by using sound waves to produce high-resolution images of the prostate gland, offering detailed views of its size, shape, and consistency. This helps urologists accurately evaluate the prostate's anatomy and detect potential pathological issues, whether benign or malignant.

Key aspects of TRUS:

1. Prostate imaging: TRUS provides highly accurate images of the prostate, which is located near the rectum, making it an ideal method for visualising the gland. This allows for a precise assessment of prostate size, shape, architecture, and potential abnormalities, aiding in the diagnosis of conditions like benign prostatic hyperplasia (BPH) and prostate cancer.
2. TRUS-guided biopsy: One of the primary uses of TRUS is to guide prostate biopsies, a standard procedure for diagnosing prostate cancer. The accuracy of TRUS in mapping the prostate and targeting areas of concern significantly improves cancer detection. However, while TRUS is indispensable for biopsy guidance, it's typically not used for other urological conditions beyond cancer diagnosis.
3. TRUS and MRI fusion: Advances in technology have combined TRUS with MRI fusion, where MRI images are overlaid with the real-time TRUS images to enhance targeting precision. This technique is known as MRI-TRUS fusion biopsy and represents the gold standard in diagnosing prostate cancer. It maximises the chances of detecting cancer by accurately targeting abnormal areas identified in MRI scans, ensuring that biopsies are as effective as possible.
4. Assessing benign prostatic hypertrophy (BPH): TRUS is especially valuable for evaluating BPH, a condition where the prostate enlarges, often leading to urinary symptoms. TRUS allows urologists to determine the size and shape of the prostate, which directly influences treatment decisions. For example, prostates enlarged in specific ways, such as with a prominent middle lobe, may benefit from surgical resection, while more uniformly enlarged prostates may be treated with less invasive options like laser ablation.
5. Tailored treatment plans: TRUS helps guide treatment choices by providing detailed information about the prostate's condition. It can distinguish between different forms of prostate enlargement and can also help calculate PSA (prostate-specific antigen) density. This is particularly useful for stratifying patients with raised PSA levels, helping urologists assess the likelihood of malignancy versus benign conditions.
6. Quick and effective diagnosis: One of the key advantages of TRUS is its ability to offer detailed information during a quick, initial consultation. It can give a clear picture of the prostate's size, shape, and potential pathology, all in a non-invasive procedure. This allows for fast decision-making on whether further tests or treatments are necessary, making it a highly efficient tool in urology.

In summary, TRUS is an essential and versatile tool in prostate healthcare, providing detailed insights that guide the diagnosis and treatment of both benign and malignant conditions. It not only plays a critical role in detecting prostate cancer but also helps urologists assess and manage BPH, ultimately improving patient outcomes through more personalised care.